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Chapter 2
The Need for Quantitative SPECT in Clinical
Brain Examinations
Hidehiro Iida, Tsutomu Zeniya, Miho Yamauchi, Kazuhiro Koshino,
Takashi Temma, Satoshi Iguchi, Makoto Yamazaki, Junichiro Enmi,
Naoya Kondo, Nobutoku Motomura, and Jyoji Nakagawara
Abstract This report describes details of the requirements and practical procedures
for quantitative assessments of biological functional parametric images of the brain
using 123I-labeled tracers and clinical SPECT systems. With due understanding of the
physics and the biological background, this is considered achievable even under
clinical environments, provided that data are appropriately acquired, processed, and
analyzed. This article discusses how potential hurdles have been overcome for
quantitatively assessing quantitative functional parametric images in clinical settings,
with successful examples that provided additional clinically useful information.
Keywords SPECT • Quantitation • 123I-labeled radiopharmaceuticals •
Reconstruction • Functional imaging
2.1 Introduction
Current clinical practice using SPECT relies largely on the interpretation of qual-
itative images reflecting physiologic functions. However, a quantitative analysis
could provide further information to assist in the interpretation of disease status and
treatment decisions. Methodological progress has made a quantitative determina-
tion of physiological functions through imaging feasible for brain scans, including
parameters like the cerebral blood flow (CBF) and cerebral flow reactivity (CFR)
after pharmacological vasodilatation and also neuro-receptor functions and others.
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The usefulness of such data has generally been limited to research due to the logistical
complexity of quantitative examinations. Extensive work has then been carried out to
make quantitative study doable in clinical environments, and some relevant study
protocols are today generally accepted in clinical institutions in Japan.
Statistics show that 20 % of all SPECT clinical scans, namely approximately
20,000 scans annually, are carried out for the brain, mostly on patients with neuro-
logical (67 %) and cerebral vascular diseases (33 %), which is a much larger number
than in other countries. Quantitative assessments of CBF (mostly with CFR) using
123I-iodoamphetamine (IMP) comprise 5.6 % of all SPECT scans. Further, software
programs assisting in the diagnosis are utilized with most brain scans, employing
statistical analysis such as the 3D-SSP of Minoshima and others [1–5].
123I-IMP and other 123I-labeled tracers such as 123I-iomazenil and 123I-FP-CIT
are approved for clinical use and can be employed in a quantitative analysis for
demonstrating biological parametric images. Attenuation correction and scatter
correction are necessary factors when conducting quantitative studies. Additional
unique error of septal penetration is present when employing 123I-labeled
radiopharmaceuticals.
With SPECT scans there is the advantage over PET in the availability of the
necessary scanner in clinical institutions. Availability of radiopharmaceuticals is
another factor which would make conducting of such clinical research simple and
straightforward. Standardization of the techniques is essential to be able to generate
quantitative functional images that are consistent among institutions and SPECT
scanners. This is important particularly when applying diagnosis-assisting software
programs, to ensure consistent results independent of the SPECT devices installed
at different institutions. The ability to refer to and compare results from different
institutions or databases created at different institutions also requires that quantita-
tive and reproducible results are needed.
This article describes how an integrated system was developed to enable a
quantitative assessment of images of biological functions consistent among insti-
tutions in clinical setting with 123I-labeled radiopharmaceuticals. To achieve this
we describe the physics and technical background needed for the quantitation.
Application and verification of the developed software packages as clinical diag-
nostic tools, and how users have been supported, will also be discussed for
123I-IMP, 123I-IMZ, and 123I-FP-CIT examinations.
2.2 Requirements for Quantitative Reconstructions
in SPECT
2.2.1 Scatter Correction
It is commonly accepted that the scatter and attenuation occurring in an object are
the two major error factors with SPECT, and these need to be compensated for in
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the quantitative imaging. One technique to estimate the scatter distribution is to
acquire projection data for additional energy windows in addition to the main
window that covers the main peak. Selecting two additional windows below and
above the main peak, the so-called triple-energy window (TEW) [6] method, is a
commonly applied technique, in which acquired counts of the lower and upper
windows are subtracted from those of the main window, and the reconstruction is
then performed using the scatter-subtracted projection data. An advantage of this
technique is that the procedures automatically compensate for the photons pene-
trating the collimator (see below).
An alternative approach is based on estimating the scatter from the scatter-
uncorrected reconstructed images using the attenuation coefficient distribution. A
formulation like the Klein-Nishina formula is commonly applied to simulate the
scatter projection for a given tracer distribution and is termed the single scatter
simulation (SSS) method [7]. This calculation can also be performed by Monte
Carlo simulation (MCS), where simplification is effective to accelerate the calcu-
lations and ensure minimal loss of accuracy [8]. One further simplified approach is
also feasible, by referring to the emission and attenuation data available in the
projection domain; this was originally proposed by Meikle et al. [9] and was further
optimized for 99mTc [10], 201Tl [11, 12], and 123I [13] in our group. A scatter
fraction is empirically defined for a radioisotope as a function of the attenuation
factor, which is then used to scale the simulated scatter distribution. This is the
transmission-dependent convolution subtraction (TDCS) method and is applied to
the geometric mean projection data. A number of verification studies have been
carried out to ensure the accuracy of this method, but it must be noted that accuracy
with the SSS and MCS theoretical methods is often limited because a number of
factors are not taken into account. Our earlier work by a careful Monte Carlo
simulation demonstrated that a non-negligible amount of scatter originates from
outside objects such as the detector and scanner itself [14] and that this may be a
source of errors if not taken into account.
With the software developed by our group for quantitative SPECT reconstruc-
tion (QSPECT), we have incorporated MCS- and TDCS-based scatter correction
methods, and extensive work has shown support for this in the verification of the
TDCS method for brain SPECT examinations. Due to the robustness and applica-
bility when combined with other correction procedures, all results in the following
will be with the TDCS scatter correction.
2.2.2 Septal Penetration in the Collimator
In addition to scatter and attenuation, 123I has a further error arising from penetrat-
ing photons generated by high-energy gamma rays (>500 keV) emitted from the
123I. These penetrating photons cause a down-scatter through the collimator and
escaping photons from the scintillator, resulting in non-negligible levels of bias in
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the energy spectrum and therefore an offset in the projection data for the selected
energy window (see Fig. 2.1).
Here it must be noted that the magnitude of the offset in the projection data due
to the penetrating photons varies dependent on the collimator. With typical
low-energy collimator sets, this represents a large amount, due to the thin walls
of such collimators, while with typical 123I-specifically designed collimator, the
amount of offset is suppressed, due to thicker collimator walls. An example of a
comparison of projection data obtained from two collimator sets of a typical
low-energy high-resolution collimator (LEHR-para) and a 123I-specific low-
medium-energy general-purpose collimator (LMEGP-para) from one vendor is
shown in Fig. 2.2. Collimator penetration is clearly visible with LEHR-para, but
a
b
Fig. 2.1 (a) Error sources which need to be compensated for in quantitative reconstruction of
brain SPECT images, attenuation, scatter, and photon penetration. (b) Energy spectrum for 123I in
a typical LEHR collimator. The significantly high background signal is a source of errors, caused
by the high-energy photons emitted by the 123I itself
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not with LMEGP-para for a 123I-syringe and also on the striatal brain phantom
(Fig. 2.2a). This difference causes the different reconstructed images of uniform
cylindrical phantoms (Fig. 2.2b). It is important to note that the counts are decreased
in the center of the cylindrical phantom when the attenuation correction is not applied
to the data obtained with LMEGP-para collimator, while the decreased counts in the
center is not visible with LEHR-para. The TEW technique is effective to compensate
for the penetrating high-energy photons. With the scatter correction performed by the
TEW technique, these penetrating photons are automatically compensated for. This is
practical and effective, but at the expense of increased statistical noise.
In the QSPECT software, the penetration component is determined empirically
for a collimator, as an extension of the TDCS scatter correction, as described in an
earlier report [13].
2.2.3 Attenuation Correction
The Chang method [15] is the most common approach for attenuation correction
(AC) in brain SPECT. This method utilizes an attenuation coefficient (μ) map
a b
Fig. 2.2 (a) Typical projection data for a syringe-shaped phantom (left) and for a striatum
phantom from Radiology Support Devices (Long Beach, LA, USA) (right) measured with 123I-
dedicated LMEGP-para and conventional LEHR-para collimator sets. (b) Reconstructed images
for a uniform cylindrical phantom filled with 123I-solution with and without attenuation correction
(AC), scatter correction (SC), and photon penetration correction (PC). Different amounts of
photon penetration are clearly visible as a high background outside the phantom on the projection
data. In the projection data of the striatum phantom, striatum-to-whole brain ratio is also altered
due to the penetrating photons. The reconstructed images also became different when not com-
pensated. An appropriate correction procedure is important to compensate for the penetration for
each set of the collimator
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which is commonly generated by detecting the head contours of the reconstructed
images to which the AC is applied. The μmap can also be obtained from CT or from
images of other modalities. The AC factors are then estimated for each pixel as an
average over the 360 views with the attenuation coefficient (μ) map and is
multiplied into the non-AC reconstructed images. The Chang method is empirical
but the results are considered acceptable in most brain examinations. For the
quantitative reconstruction, a uniform μmap is feasible if errors< 5 % are accepted
in the deep parts of the brain. However, absolute values have to be carefully defined
so as to make the pixel counts of the reconstructed images independent of the size of
the object. This is also the case if a CT-based μmap is utilized in the reconstruction.
2.2.4 Attenuation Coefficient Map
Two possibilities are given to define the attenuation μ map in QSPECT software.
One is to import externally generated attenuation μ maps, typically calculated from
the Hounsfield unit (HU) images generated from a CT scan. Careful attention is
needed to correct for the beam hardening effects when converting the attenuation
map assessed with the continuous and rather low-energy photons to the quantitative
HU and μ values corresponding to photons with single energy included in the
energy window. Another possibility is to generate a homogeneous μ map by
detecting the head contours. Extensive efforts have been made to provide the best
accuracy in the head-contour detection algorithm, and a threshold was determined
from the sinogram rather than the projection or the reconstructed images, and sine
wave constraint was applied to the scatter-uncorrected data when defining the edge
of the sinogram. Reconstruction was made for the filtered sinogram, and a threshold
was applied again to determine the head contour, ensuring that an accurate head
contour is generated. An empirically defined attenuation coefficient which effec-
tively included the contribution of the bone value was then applied [13].
An attenuation coefficient map is utilized for the attenuation correction during
the OSEM procedures and also for the scatter and penetration correction prior to the
reconstruction if one utilizes one of the SSS, MCS, or TDCS methods for scatter
correction. This attenuation coefficient map was utilized during the OSEM pro-
cedures as well as for the scatter and penetration correction prior to the reconstruc-
tion, by using the TDCS method as discussed earlier.
2.2.5 Implementation of the Collimator Aperture Model
It has been shown that implementation of a collimator aperture during the forward
projection process on the three-dimensional domain makes the SPECT reconstruc-
tion more accurate [16]. Effects of this are increased, resulting in improved contrast
and also suppression of statistical noise. The collimator aperture model shown in
22 H. Iida et al.
Fig. 2.4 was implemented with the QSPECT reconstruction software for both the
geometric mean and normal projection data. See further below.
2.2.6 SPECT Reconstruction
Two methods are known to quantitatively reconstruct images in the brain SPECT
which will be discussed here. The filtered back projection (FBP) method is the one
and has been the standard for reconstruction. For the FBP, the scatter correction has
to be applied to the projection data before the reconstruction, and TEW is a well-
established technique compensating for the septal penetration during the recon-
struction. An attenuation correction is performed after the reconstruction in most
cases based on the Chang method with an edge detection technique to generate
homogeneous μ maps. The use of CT-based attenuation coefficient images is also
possible, but selection of the absolute μ values needs careful consideration, and
there are no published reports on how consistent results can be obtained with this
technique with different equipment arrangements. A preliminary study carried out
in Europe [17] showed unacceptable levels of variation and inconsistencies among
sites. The reasons for the inconsistencies are unknown, but it was suggested that
further careful evaluations are needed to standardize the detailed procedures.
Although the FBP approach is straightforward and has been considered a standard,
the method is limited when implementing new functionality to maximize the
accuracy and image quality.
An alternative reconstruction method for SPECT is based on the maximum-
likelihood expectation maximization (MLEM) algorithm, in which images are
calculated with iterative procedures. Attenuation can be implemented in the for-
ward projection process, so that the calculated reconstructed images are corrected
for attenuation. The ordered-subset maximum-likelihood expectation maximization
(OSEM) method is often utilized to accelerate convergence, as will be discussed
later in this article. It must be noted that the TEW-based scatter correction includes
correction also for the penetration, while currently the existing simulation-based
scatter correction method does not include a penetration correction, and thus
requires further development.
The QSPECT software employs the OSEM approach. A schematic representa-
tion of the process of the reconstruction in QSPECT software is shown in Fig. 2.3.
Systematic errors arise due to neglecting higher μ values in the skull, but the effect
is within 5 % in the middle part of the brain and also in other areas outside the
cerebral tissue [13]. The following three formulations were implemented in the
program. Suitable formulation can then be selected to best fit each clinical protocol.
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2.2.6.1 OSEM on 2D Domains for the Pre-scatter Corrected Geometric
Mean Projection
The first formulation is essentially identical to the one also described in earlier
studies [9–11, 13]. Reconstruction is performed for each two-dimensional tomo-
graphic slice, with the projection corrected for scatter before the reconstruction.
The pixel counts of the reconstructed image λnþ1j are calculated from the counts of
the previous image λnj . The scatter compensated projection data by the TDCS
method [18] was applied, and the formulation for the geometric mean projection
data is given as follows:
Fig. 2.3 Diagram illustrating the quantitative reconstruction protocol implemented in the
QSPECT reconstruction software. The emission data are initially reconstructed with filtered
back projection (top right image) to allow the brain outline to be determined and the μ map for
the attenuation correction to be determined by assigning a uniform attenuation coefficient value of
0.1603 cm1 to the detected brain volume. The μ map is forward projected to provide the
attenuation projections for the scatter correction to calculate scatter- and penetration-compensated
projection. The scatter correction is carried out using TDCS method; thus, the projection data
becomes geometric mean data. Then, OSEM reconstruction is applied with the attenuation
correction to generate the attenuation and scatter corrected images. The collimator aperture
correction (APC) can also be applied in the reconstruction process using Eq. (2.2) (Figure is
from Iida et al. [28])
















where yi is the count in the projection data corrected for the scatter and the
collimator penetration, cij is a factor for the contributions from the projection
pixel to the image pixel, exp μLið Þ is the net attenuation factor for each of the
geometric mean projections. Note that the projection data has to be corrected before
the reconstruction calculations, eg by the TDCS scatter correction.
2.2.6.2 OSEM on 3D Domains for the Pre-scatter Corrected Geometric
Mean Projection
This formulation includes the collimator aperture correction, and the reconstruction
is carried out nearly wholly in a three-dimensional domain. The scatter compen-
sated projection data by the TDCS method [18] was applied, giving the formulation
















where wij represents the collimator dependent blurring of the spatial resolution
shown in Fig. 2.4. Note that the projection data has to be corrected for the scatter
before the reconstruction calculations as in the eq. 2.1 in which yi is the geometric
mean projection data already corrected for scatter by means of the TDCS method,
and cij represents the calculation of the geometric mean.
2.2.6.3 OSEM on 3D Domains Including the Scatter Correction Process





















The scatter projection at the i-th iteration, si, has to be estimated at each iteration
either by the SSS or MCS methods from the i-th reconstructed images. It is also
possible to use the TEW-based scattered projection for si. In QSPECT, an
2 The Need for Quantitative SPECT in Clinical Brain Examinations 25





was assumed to decrease
linearly with the distance
from the collimator with an
initial value. The
contribution weights, wij,
calculated from this model
were implemented in
Eqs. (2.2) and (2.3), which
compensated for the
blurring effects due to the
collimator aperture
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accelerated MCS [8] is implemented. Consequently, yi it is not necessarily the
geometric mean but may be the normal projection.
2.2.7 Calibration to Bq/mL
The QSPECT program is designed so that the pixel values correspond to the
radioactivity concentration, the cps/mL. An experiment with a syringe filled with
a 123I-labeled radioactive pharmaceutical of known radioactivity gives a calibration
factor to convert the pixel counts to the absolute radioactivity concentration which
has units of Bq/mL. The accuracy of the absolute quantitation was 10 % for 123I
in uniform cylindrical phantoms provided that the diameter is less than 16 cm. For
the future, this feature could be of use in internal dosimetry quantitation of
radiotherapy agents such as 177Lu peptides.
2.2.8 Dead Time Count Loss
The counting rate performance should be sufficiently high in clinical SPECT
scanners, e.g., count losses <1 % up to a counting rate of 70 kcps. This would
hold for 99mTc and other commonly used SPECT radiopharmaceuticals, but may
not in 123I-labeled tracers. The true counting rate of the system could be much
higher than the observed rate for the given main window, attributed to the incidence
of a large amount of penetrating photons originated from the high-energy gamma
rays (>500 keV). Particularly, low-energy dedicated collimators such as LEHR
collimators can accept large amounts of penetrating photons, and there may be a
significant counting loss at counting rates much below 70kcps. Errors could be
mostly in phantom experiments but may be smaller in clinical scans. It is however
important to confirm the maximum counting rate that maintains the linearity of the
SPECT counts to the true radioactivity.
2.3 Phantom Experiments
A number of studies have been carried out to evaluate the adequacy of the QSPECT
reconstruction programs. The experiments were on geometrically shaped phantoms
such as cylindrical phantoms and also on phantoms simulating the cerebral blood
flow distribution and striatum structure with realistic head contours and skull
structures. These phantom experiments are useful in validating the reconstruction
procedures and also to ensure quality control of the data acquisition procedures.
2 The Need for Quantitative SPECT in Clinical Brain Examinations 27
2.3.1 Uniform Cylindrical Phantom
The cylindrical phantom gives information of how uniform images are obtained for
uniform distributions of radioactivity. Image homogeneity could be degraded by
several factors in relation to inappropriate corrections for attenuation, to scatter and
penetration, and also to the insufficient quality control. The quality control includes
the procedures for adjusting and correcting for inhomogeneous sensitivity,
mistuned position linearity, misaligned center of rotation, large attenuations in
the head holder, and other factors. Experiments to confirm the homogeneity for
uniform phantom are highly suggested to ensure that the regional activity quanti-
tation is not suffered from one of error factors mentioned above. However, it should
be noted that inappropriate definition of the head contour and inconsistently defined
attenuation coefficient values in relation to the presence of the skull may not be
evaluated from the uniform cylinder phantom experiment.
2.3.2 3D Brain Iida Phantom for CBF Quantitation
Geometrically shaped phantoms are limited in simulating realistic head contours,
the presence of the bone and trachea, and also the realistic radioactivity distribution.
Therefore, dedicated brain-simulating phantoms are often desired to evaluate the
overall accuracy of reconstructed images in realistic situations. We have developed
a three-dimensional brain phantom (Iida phantom) that simulates the CBF distri-
bution in cortical gray matter, with bone, trachea, and realistic head contours
[19]. As shown in Fig. 2.5, accuracy of the QSPECT software can be evaluated
by referring regional radioactivity concentration on the reconstructed images with
those of design images of this phantom. This experiment would be useful if one
wish to evaluate the accuracy of reconstructed images for multicenter clinical
studies using SPECT techniques.
Differences in the spatial resolution have to be assessed when comparing SPECT
images acquired from different SPECT systems, because the differences in the
spatial resolution causes different quantitative values due to the partial volume
effect [20]. Hoffman 3D phantoms [21] was utilized to assess and to compensate for
the different spatial resolution in the cerebral FDG uptake images acquired at
different institutions using different PET systems on healthy volunteers [20]. The
Iida brain phantom is also useful to evaluate and equalize the spatial resolution of
SPECT images obtained from different sites and probably better suited to SPECT,
due to its importance in the determination of head contour in SPECT scans.
Yamauchi et al. [22] demonstrated that equalization of the spatial resolution
significantly reduced the inter-institutional variation of the normal database of
rest- and acetazolamide-CBF images among three institutions. The Iida brain
phantom may be better suited than the 3D Hoffman phantom when one intends to
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assess attenuation or scatter-related variations among different PET/SPECT
scanners.
2.3.3 Striatum Phantom for Dopamine Transporter Imaging
For dopamine transporter imaging using 123I-FP-CIT, a phantom simulating the
striatum uptake of 123I-FP-CIT with homogeneous background in the whole brain
region (Radiology Support Devices, Long beach, LA, USA) was utilized to eval-
uate the accuracy and also to calibrate the inter-institutional variations in
Fig. 2.5 (Top) X-ray CT images of the developed phantom, which contain water and bone-
equivalent liquid in the cortical gray matter and bone components of the phantom, (Middle) digital
design of the gray matter area of the phantom after smoothing with a 16 mm full-width at half
maximum Gaussian filter, and (Bottom) SPECT images of the phantom filled with 123I solution in
the gray matter compartment and K2HPO4 solution in the bone compartment. All images are
aligned to the digital design. The SPECT images showed good agreement with the digitally
designed images. Spots shown with arrows (a–e) demonstrated are examples which indicated
good agreement between the digital design and 123I-SPECT images (Figure is from Iida et al. [19])
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multicenter evaluations in the EU [23]. The QSPECT reconstruction program was
also evaluated using this phantom to assess the accuracy of the specific binding
ratio (SBR) values [24], by referring the values calculated from the true radioac-
tivity in the striatum compartments relative to the whole-brain background concen-
tration. Results demonstrated that the SBR values measured using QSPECT
software agreed well with those determined from the true radioactivity concentra-
tions. Variation was less than 1/3 of those with FBP reconstruction including the
attenuation corrections. This suggested smaller inter-institutional/inter-vendor var-
iations less than 1/3 with QSPECT when compared with FBP. This difference
corresponds to the decline of both sensitivity and specificity from 97 to 78 % in
our preliminary simulation study. It is therefore of a paramount importance to
establish an accurate reconstruction methodology in order to provide a good
diagnostic performance in clinical settings. Further careful evaluation is to be
carried out.
2.3.4 QSPECT Program Packages
The program package of QSPECT uses a wrapper written in JAVA to run several
programs written in C language for Microsoft Windows systems and also includes
programs for reconstructing SPECT images, co-registering images, re-slicing,
calculating functional images, and printing summary logs. Packages are prepared
for the given data processing protocols for the given radiopharmaceuticals. Of
those, a package to calculate the rest- and acetazolamide-CBF images with 123I-
IMP and the specific binding ratio (SBR) values with the distribution volume ratio
(DVR) images with 123I-FP-CIT have been utilized to support clinical diagnosis.
The programs are also utilized to support clinical research.
2.4 Adequacy and Impact in Clinical Scans
2.4.1 Dopamine Transporter Function (SBR Quantitation)
Using 123I-FP-CIT
Figure 2.6 shows an example of an image of a 123I-FP-CIT scan on a young healthy
volunteer (29 years old, male) acquired using a three-head SPECT camera from
Toshiba (Tochigi, Japan) fitted with a LHR-fan collimator. The reconstruction was
carried out according to Eq. (2.2), which includes the TDCS scatter correction for
the geometric projection data and the collimator aperture correction. It can be seen
that the head contour was well delineated, as indicated by the red arrows. This is
attributed to the carefully designed algorithm: the contour detection with the sine
function constraint on the sonogram prior to the scatter correction. With the
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improved sensitivity and spatial resolution achieved using the triple head SPECT
camera with a fan beam collimator designed for 123I-nuclides, the collimator
aperture model was effective to enhance and provide better striatum-to-background
contrast with minimal enhancement of the background noise, though the SBR
values essentially remained without changes. There may be lots of application
areas where improved image quality can make contributions in clinical settings.
Fig. 2.6 An example of an image of 123I-FP-CIT for a healthy 29-year-old male volunteer. The
scan was made using the Toshiba 9300R (three-head camera) fitted with an LMEGP-fan collima-
tor. Reconstruction was carried out according to Eq. (2.2) and includes the collimator aperture
correction. The head contour is well delineated using the edge detection method implemented in
the QSPECT software, as shown with the red arrows
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2.4.2 Central Benzodiazepine Receptor Imaging Using
123I-IMZ (Neuron Damage/Residual)
The radiopharmaceutical 123I-iomazenil (IMZ) is a radiopharmaceutical approved
for clinical diagnosis to assess local neuronal damage in patients with epilepsy in
Japan. There are also other applications to identify the presence of neuronal damage
in the prefrontal areas of patients with neurological deficits after chronic ischemia
(or Moyamoya disease) and traumatic brain injuries. We have aimed to highlight
significantly damaged areas using 123I-IMZ and SPECT in such patients by refer-
ring to normal patterns by means of 3D-SSP [1] [3, 5]. The challenge is to verify
that identical data can be obtained from different SPECT systems installed in
different institutions. Consistency is essential in order to utilize a common (normal)
database rather than generating separate ones at each institution. At present, we
have confirmed that a normal database for 123I-IMZ generated at two independent
institutions installed with different vendor SPECT systems showed smaller varia-
tions when QSPECT with AC, SC, and PC was utilized, as compared with vendor
FBP reconstruction employing AC only. It was also observed that while vendor
reconstruction provided different damage regions with the 3D-SSP analysis using
the normal database generated at different institutions, only small differences could
be seen between two sets of the normal database with QSPECT reconstruction. This
is one area where the standardization of SPECT can make a significant contribution.
2.4.3 Rest- and Acetazolamide-CBF Using 123I-IMP (The
Dual-Table Autoradiography Method)
Extensive work has been conducted to establish and validate quantitative assess-
ments of CBF at rest and after administration of acetazolamide with 123I-IMP and
dynamic SPECT using the QSPECT program packages (Fig. 2.7). At present, the
QSPECT software packages have been shown to be able to handle the data obtained
from most SPECT cameras fitted with parallel beam collimators (see Table 2.1). A
total of more than 60,000 scans have been carried out in Japan between 2006 and
January 2015, with 16,000 scans in 2014. The scans were mainly to assess the risk
of hyper-perfusion after revascularization therapy in patients who are candidates for
coronary artery stents and for coronary endarterectomy.
The 123I-IMP has a high first-pass extraction fraction and is capable of assessing
quantitative CBF values for a physiologically wide range of blood flows
[25, 26]. The object was to make the quantitative assessment of the rest- and
acetazolamide-CBF images from scans obtained in a single session, with two
injections of 123I-IMP at 30 min intervals, to establish the ischemic status in the
scans of each patient. A sophisticated compartment model was applied (called dual-
table ARG) [27] to make it possible for the stress CBF images to be calculated using
table look-up procedures without the need for image subtraction. This method
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appeared not to result in increases in statistical noise and more importantly was able
to provide quantitative CBF images with minimal errors and only little inconsis-
tency between the rest- and acetazolamide-CBF assessments. A number of studies
were carried out to verify the method in clinical settings, funded by the Ministry of
Health, Labour and Welfare Research Foundation from the year of 2007 for 3 years
as follows:
(a) There was a fairly good intra-institutional reproducibility of rest- and
acetazolamide-CBF images for the same patient, approximately 10 % with
44 patients at nine institutions [28].
(b) Inter-institutional reproducibility of rest- and acetazolamide-CBF images was
approximately 6 % in nine patients on 18 data points [29]. An example case is
shown in Fig. 2.8.
(c) Consistent results for rest and acetazolamide CBF at rest and after acetazol-
amide in healthy volunteers among three institutions (a total of 32 healthy
volunteers) [22].
(d) Agreement with PET scan results both on relative distribution and absolute
values was shown in one institution for five patients [28].
Fig. 2.7 MR and CBF images at rest and after acetazolamide stress assessed with 123I-IMP and
the dual-table ARG method on two typical low-risk patients (stage I) and a patient with high-risk
(stage II) ischemia (Figure is from Iida et al. [28])
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This examination is one good example that demonstrates the contribution of
quantitative SPECT in clinical settings. Results of 3D-SSP shown in Fig. 2.8 are
helpful in understanding the severity of ischemia and the risk status in patients with
major artery occlusion or stenosis. This would also contribute to evaluate a number
of therapeutic trials in the future.
2.5 Quality Control of the SPECT Scanner
It must be noted that standardization of the quantitative SPECT examination
requires detailed self-defined protocols, including for the procedures of the admin-
istration, blood sampling, instructions to patients and patient movement, QC of
SPECT devices, SPECT acquisition workflow, data pre-processing, and QSPECT
reconstruction. Active feedback to deal with possible adverse events related to
above procedures at clinical institutions appeared to be effective to maintain the
reliability of the clinical scan findings. From July 2009 till May 2011, 139 cases
were defined as potentially posing problems or possibly resulting in adverse events
Table 2.1 List of SPECT camera (3/8 NaI scintillator) and collimator combinations to which
QSPECT can be applied. TDCS parameters have been defined for those systems prior to the first
clinical examination
SPECT camera Collimator
Toshiba GCA-9300 3/8inch N2(LEHR fan),
N1(LESHR fan). LEHR
para
GCA-7200 N2(LEHR fan), N1
(LESHR fan), LEHR para
LEGP para
ECAM N2(LEHR fan), LMEGP
para
Symbia LMEGP para
Siemens ECAM 3/8inch LEHR para, LMEGP para
Symbia LEHR para, LMEGP para
GE Millennium VG 3/8inch LEGP para, LEHR para
Infinia ELEGP para, LEHR para
Hitachi
(Philips)
ADAC forte JET stream Philips
BrightView Philips SKYLight
3/8inch VXGP para
CHR para, LEHR para,
MEGP para





IRIX 3/8inch LEGP para, LEHR para
AXIS LEGP para
PRISM2000 LEHR para
PRISM3000 LEGP para, LEHR para
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at 67 institutions. Claims were mostly unexpected low CFR values or unexpectedly
low or high absolute CBF values. The software package was designed to keep a
record of the complete calculation process, and among the data obtained in this
manner, the tissue time-activity curve (tTAC) analysis for sequential short frame
dynamic images and dynamic projections appeared to be helpful to identify the
sources of errors. Of the 139 cases identified, 64 (42 %) did not suggest errors in the
data or in the calculation process, as the observed CFR or small CBF values could
be confirmed from results of the tTAC analysis, both in the dynamic reconstructed
images as well as in the projection data. In other studies, the tTAC analysis was able
to identify errors in the blood radioactivity concentrations (n¼ 26), in the cross
calibration procedures (n¼ 25), in the IMP administration (n¼ 17) due to the
patient motion (n¼ 11), and other factors including insufficient SPECT QC
(n¼ 11). Errors in the software program were not identified in any of the studies.
Fig. 2.8 Stereotactic extraction estimates based on the JET study (SEE-JET) images [4] of a
patient obtained in institutions O and Y. The Rt Lat and Lt Lat indicate the right and left
hemisphere outer lateral images, respectively. Cerebral blood flow at rest (rest CBF), CBF after
the acetazolamide challenge (Diamox CBF), the cerebrovascular reserve (vascular reserve), and
severity of hemodynamic cerebral ischemia (STAGE) are shown as three-dimensional cerebral
surface images. Images are almost visually identical, from institutions O and Y (Figure is from
Yoneda et al. [29])
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The feedback provided in the information to the clinical institution was evaluated to
be effective to improve the quality of the examination results.
It is possible that the quality of reconstructed SPECT images is degraded by
inaccurate reconstruction parameter settings in relation to the attenuation coeffi-
cients, accuracy of the head contour determination, inefficient statistical treatment,
and also poor quality control (QC) of the SPECT device. It should be noted that
there are no standard guidelines (like the NEMA standard) for reconstructed
SPECT images, only for projection data. One contribution of the QSPECT recon-
struction package is the ability to evaluate the image quality and accuracy on one
domain with different systems. It was apparent that the engineers at the vendors
should be encouraged to make effort to improve the quality of the reconstructed
images rather than only on the projection data. Active feedback to the users at the
clinical institutions is also essential to improve the quality of the examination in the
quantitation. We also considered the FBP reconstruction with the scatter correction
of Chang, for the scatter corrected-projection with TEW would be another possi-
bility for standardization among different institutions. Systematic study has to be
coordinated to validate the technique in multicenter settings.
2.6 Summary and Future Directions
The QSPECT package is able to reconstruct quantitative tomographic images from
projection data acquired using commercial SPECT equipment. The adequacy was
demonstrated with a series of phantom experiments. More importantly, the ade-
quacy of images of biological functions and the use of stereotactic statistical
analysis software were shown for some protocols in patient populations. Overall,
this suggests the adequacy of using clinical SPECT devices for multicenter clinical
studies. It is also possible to encourage the use of quantitative reconstruction with
diagnosis-assisting software in clinical settings; this would enable an extension of
the contribution of SPECT in evaluations of disease severity and so assist in
decision making. Further systematic work should be designed to prove this concept
for the various tracers in the various clinical settings.
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